Literature DB >> 19505243

Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.

Raghav Goel1, Neha Shah, Rachana Visaria, Giulio F Paciotti, John C Bischof.   

Abstract

AIM: In this study, we describe the biodistribution of CYT-6091, a colloidal gold (Au)-based nanomedicine that targets the delivery of TNF-alpha to solid tumors. MATERIALS &
METHODS: A single intravenous injection of CYT-6091 coated with 5 microg TNF-alpha was given to human prostate tumor-bearing or naive (without tumor) nude mice. Tissues were harvested and analyzed at specific time points for Au nanoparticles by atomic emission spectroscopy and TNF-alpha by ELISA.
RESULTS: The two constituents of CYT-6091, TNF-alpha and Au, exhibited different behavior in blood, with TNF-alpha showing a faster decay than the Au nanoparticles. Between 0 and 4 h after injection, TNF-alpha showed a preferential accumulation in the tumor. Au was observed to accumulate preferentially in the liver between 4 and 12 h, and showed some clearance over time (4 months).
CONCLUSION: These data suggest that CYT-6091 delivers TNF-alpha preferentially to the tumor and that upon TNF-alpha degradation, the liver takes up Au, which is cleared slowly over time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505243      PMCID: PMC2727870          DOI: 10.2217/nnm.09.21

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  19 in total

1.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.

Authors:  B Devika Chithrani; Arezou A Ghazani; Warren C W Chan
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

Review 2.  Emerging implications of nanotechnology on cancer diagnostics and therapeutics.

Authors:  Alex G Cuenca; Huabei Jiang; Steven N Hochwald; Matthew Delano; William G Cance; Stephen R Grobmyer
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

Review 3.  Immunological properties of engineered nanomaterials.

Authors:  Marina A Dobrovolskaia; Scott E McNeil
Journal:  Nat Nanotechnol       Date:  2007-07-29       Impact factor: 39.213

Review 4.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Authors:  Marina A Dobrovolskaia; Parag Aggarwal; Jennifer B Hall; Scott E McNeil
Journal:  Mol Pharm       Date:  2008-05-30       Impact factor: 4.939

5.  Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery.

Authors:  Rachana K Visaria; Robert J Griffin; Brent W Williams; Emad S Ebbini; Giulio F Paciotti; Chang W Song; John C Bischof
Journal:  Mol Cancer Ther       Date:  2006-04       Impact factor: 6.261

Review 6.  Emerging use of nanoparticles in diagnosis and treatment of breast cancer.

Authors:  Maksym V Yezhelyev; Xiaohu Gao; Yun Xing; Ahmad Al-Hajj; Shuming Nie; Ruth M O'Regan
Journal:  Lancet Oncol       Date:  2006-08       Impact factor: 41.316

7.  Zonal heterogeneity of rat hepatocytes in the in vivo uptake of 17 nm colloidal gold granules.

Authors:  M J Hardonk; G Harms; J Koudstaal
Journal:  Histochemistry       Date:  1985

8.  Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor.

Authors:  Jeffrey M Farma; Markus Puhlmann; Perry A Soriano; Derrick Cox; Giulio F Paciotti; Lawrence Tamarkin; H Richard Alexander
Journal:  Int J Cancer       Date:  2007-06-01       Impact factor: 7.396

9.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jiwen Zheng; Jeffrey D Clogston; Nader Ayub; Parag Aggarwal; Barry W Neun; Jennifer B Hall; Scott E McNeil
Journal:  Nanomedicine       Date:  2008-12-13       Impact factor: 5.307

10.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.

Authors:  Wim H De Jong; Werner I Hagens; Petra Krystek; Marina C Burger; Adriënne J A M Sips; Robert E Geertsma
Journal:  Biomaterials       Date:  2008-02-01       Impact factor: 12.479

View more
  60 in total

1.  Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties.

Authors:  Neha B Shah; Gregory M Vercellotti; James G White; Adrian Fegan; Carston R Wagner; John C Bischof
Journal:  Mol Pharm       Date:  2012-07-23       Impact factor: 4.939

2.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

3.  Low-dose gold nanoparticles exert subtle endocrine-modulating effects on the ovarian steroidogenic pathway ex vivo independent of oxidative stress.

Authors:  Jeremy K Larson; Michael J Carvan; Justin G Teeguarden; Gen Watanabe; Kazuyoshi Taya; Evan Krystofiak; Reinhold J Hutz
Journal:  Nanotoxicology       Date:  2014-12       Impact factor: 5.913

4.  Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.

Authors:  Steven K Libutti; Giulio F Paciotti; Adriana A Byrnes; H Richard Alexander; William E Gannon; Melissa Walker; Geoffrey D Seidel; Nargiza Yuldasheva; Lawrence Tamarkin
Journal:  Clin Cancer Res       Date:  2010-09-27       Impact factor: 12.531

5.  A Raman-based endoscopic strategy for multiplexed molecular imaging.

Authors:  Cristina L Zavaleta; Ellis Garai; Jonathan T C Liu; Steven Sensarn; Michael J Mandella; Dominique Van de Sompel; Shai Friedland; Jacques Van Dam; Christopher H Contag; Sanjiv S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-23       Impact factor: 11.205

Review 6.  Applications of nanoparticles in the detection and treatment of kidney diseases.

Authors:  Chris Brede; Vinod Labhasetwar
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

7.  Preclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imaging.

Authors:  Cristina L Zavaleta; Keith B Hartman; Zheng Miao; Michelle L James; Paul Kempen; Avnesh S Thakor; Carsten H Nielsen; Robert Sinclair; Zhen Cheng; Sanjiv S Gambhir
Journal:  Small       Date:  2011-05-24       Impact factor: 13.281

8.  In vivo detection of the effects of preconditioning on LNCaP tumors by a TNF-α nanoparticle construct using MRI.

Authors:  Isabelle Iltis; Jeunghwan Choi; Manda Vollmers; Mithun Shenoi; John Bischof; Gregory J Metzger
Journal:  NMR Biomed       Date:  2014-07-01       Impact factor: 4.044

Review 9.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

10.  Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.

Authors:  Hayley J Paholak; Nicholas O Stevers; Hongwei Chen; Joseph P Burnett; Miao He; Hasan Korkaya; Sean P McDermott; Yadwinder Deol; Shawn G Clouthier; Tahra Luther; Qiao Li; Max S Wicha; Duxin Sun
Journal:  Biomaterials       Date:  2016-06-23       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.